2026-07-16 08:59:46
Latest Post
LatentView Analytics appoints Sonal Ramrakhiani as Chief Executive Officer to Accelerate Global AI-Led Growth
Tata Capital Ltd raises USD 400 Million through Second Issuance from International Bond Markets
Emmvee Photovoltaic Power Q1 FY27 Results: Net Profit Surges 103% YoY to ₹380.3 Crore as Margins Hit Record Highs
GTPL Hathway Q1 FY27 Results: Returns to Profitability Sequentially as Revenue Tops ₹1,015 Million
Sarda Proteins Stages Major Turnaround in Q1 FY27: Net Profit Reaches ₹165.97 Lakh on Solar Cell Demand
Stock Report
Ranbaxy promoters enter clinical research
Posted On : 2006-03-17 01:18:11( TIMEZONE : IST )
The promoters of Ranbaxy Laboratories have entered clinical research segment by setting up a contract research organisation (CRO) under the name of Fortis Clinical Research activities.
